|
⚲
|
| Keyboard |
| Kenneth Carter | |
|---|---|
| Firm | |
| Address | 1500 Fannie Dorsey Rd Sykesville, MD 21784 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Neuimmune Inc | 021-406464 | Director | 0.0 M of 0.0 M |
||
| Neuimmune Inc | 021-399097 | Director | 0.1 M of 0.1 M |
||
| Bitmovin Inc | 021-396409 | Executive Officer | 25.0 M of 25.0 M |
||
| Seneca Biopharma Inc | 021-359133 | Executive Officer | 7.6 M of 7.6 M |
||
| Ascot Resources Ltd | 021-340635 | Director | 2.6 M of 2.6 M |
||
| Ascot Resources Ltd | 021-331522 | Director | 1.2 M of 1.2 M |
||
| Beta Cat Pharmaceuticals Inc | 021-315497 | Director | 2.6 M of 6.0 M |
||
| Beta Cat Pharmaceuticals Inc | 021-301052 | Director | 1.4 M of 1.4 M |
||
| Antidote Therapeutics Inc | 021-294374 | Director | 0.2 M of 0.2 M |
||
| Antidote Therapeutics Inc | 021-294019 | Director | 0.4 M of 0.4 M |
||
| Ascot Resources Ltd | 021-254029 | Director | 0.8 M of 0.8 M |
||
| Beta Cat Pharmaceuticals Inc | 021-243016 | Director | 1.0 M of 3.0 M |
||
| Neximmune Inc | 021-234073 | Executive Officer | 2.0 M of 2.0 M |
||
| Neximmune Inc | 021-221750 | Executive Officer | 3.0 M of 3.0 M |
||
| Beta Cat Pharmaceuticals Inc | 021-220563 | Director | 0.5 M of 0.5 M |
||
| Neximmune Inc | 021-208856 | Executive Officer | 0.2 M of 2.0 M |
||
| Noble Life Sciences Inc | 021-176430 | Executive Officer | 0.2 M of 0.2 M |
||
| Neximmune Inc | 021-172895 | Executive Officer | 0.3 M of 0.3 M |
||
| Neximmune Inc | 021-172893 | Executive Officer | 0.0 M of 0.0 M |
||
| Neodiagnostix Inc | 021-102270 | Director | 1.5 M of 1.5 M |
||
| Avalon Pharmaceuticals Inc | 021-87613 | Executive Officer | 0.2 M of 0.2 M |
||